A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Inclusion Criteria:
Exclusion Criteria:
New York, New York 10032, United States
Rochester, New York 14642, United States
Philadelphia, Pennsylvania 19141, United States
Newport News, Virginia 23603, United States
Ciudad Autónoma Buenos Aires, C1430, Argentina
Birmingham, B15 2TH, United Kingdom
Cambridge, CB2 0QQ, United Kingdom
Newcastle upon Tyne, NE1 4LP, United Kingdom